trending Market Intelligence /marketintelligence/en/news-insights/trending/1VpFB8Vtbt2dUVF4c436cg2 content esgSubNav
In This List

Regeneus appoints nonexecutive director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Regeneus appoints nonexecutive director

Regeneus Ltd. appointed Leo Lee as an independent nonexecutive director.

Lee is president at Merck Serono, Japan, and previously served as president of Allergan, Japan.